TITLE

FDA APPROVES BIOVAIL'S GENERIC PROCARDIA XL 30MG DOSAGE

PUB. DATE
March 2001
SOURCE
Worldwide Biotech;Mar2001, Vol. 13 Issue 3, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the final approval granted by the United States Food and Drug Administration to Biovail Corporation's generic Procardia XL drug.
ACCESSION #
4155584

 

Related Articles

  • FTC overturns generic pact.  // Medical Marketing & Media;Aug2002, Vol. 37 Issue 8, p20 

    Reports that the U.S. Federal Trade Commission has forced Bioavail Corp. and Elan Corp. to terminate their non-compete agreements for sales of the generic versions of the antihypertensive Adalat CC. Details of the proposed consent order.

  • FTC Sides with Generics Industry. Kelley, Gordon // Pharmaceutical Executive;Jun2002 Supplement, Vol. 23, p23 

    Reports on the action taken by the U.S. Federal Trade Commission (FTC) against pharmaceutical companies who delay generic introductions. Attempt of Biovail to use ancillary patent filings to delay generic competition of its heart drug Tiazac; Investigation of FTC of the delaying tactics of...

  • BIOVAIL EXTENDS MARKETING PACT FOR ZOVIRAX OINTMENT/CREAM.  // Worldwide Biotech;Feb2003, Vol. 15 Issue 2, p2 

    Reports on the extension of the marketing agreement between Biovail Corp. and GlaxoSmithKline Plc for the Zovirax (R) Ointment and Zovirax Cream, as of February 2003.

  • A tough pill to swallow. Sparks, Debra // Financial World;11/18/96, Vol. 165 Issue 14, p42 

    Questions the valuation of the stock of Biovail, which has launched the hypertension drug Tiazac. Institutional investors buying into the company; Competition posed by Cardizem, another drug; Consequences of the failure to genericize Procardia XL.

  • Canadian pharmaceutical to expand. Garza, Daniel R. // Caribbean Business;3/4/1999, Vol. 27 Issue 8, p2 

    Focuses on the additional employees projected by Biovail Corp. for its pharmaceutical manufacturing facility in Puerto Rico following the approval of its hypertension drug by the United States Food & Drug Administration (FDA).

  • Generics. Scheller, Melanie // Current Health 2;Dec96, Vol. 23 Issue 4, p30 

    Provides information on generic drugs. Differentiation of generic drugs from brand name drugs; Pricing difference between generics and brand name drugs; Drug effectiveness.

  • Generic drugs, and the consumer. Goldberg, Gene L. // Executive Health's Good Health Report;Jan1995, Vol. 31 Issue 4, p4 

    Focuses on generic drugs. Comparison of generic and brandname drugs; Advantages in using generics; Definition of generic drugs; Approval of the Food and Drug Administration.

  • Generic usage depends on type of doctor, class of drug. Snyder, Karyn // Drug Topics;11/20/95 Generics, Vol. 139 Issue 22, p2 

    Analyzes trends in the generic drug industry. Availability of more generic drugs; Gain of acceptance from doctors; Substitution of generic drugs for brands.

  • How safe are foreign-made generic drugs? Helwick, Caroline // Drug Topics;11/20/95 Generics, Vol. 139 Issue 22, p22S 

    Discusses the safety of imported generic drugs. Difficulty of regulating imported drugs; Major suppliers; Use of standard system.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics